About 200 reports

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Drugs In Development, 2021, provides an overview of the Gouty Arthritis (Musculoskeletal Disorders) pipeline landscape.Gout is a type of...

  • Musculoskeletal Disorder
  • Drug Development
  • Arthritis
  • China
  • Pharmaceutical Registrations
  • Drug Approval

Executive Summary The Global Rheumatoid Arthritis Market was valued at USD 24.46 Billion in the year 2020. Globally, the market for rheumatoid arthritis is increasing rapidly and the major factor that drives the growth of rheumatoid arthritis is the increasing ageing population. Furthermore, some evidence suggests that...

  • Arthritis
  • World
  • Health Expenditure
  • Disposable Income

China’s demand for Arthritis Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Arthritis
  • China
  • United States
  • Prescription Drug Sales
  • Industrial Production

Gouty Arthritis (Gout) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Pipeline Review, H2 2020, provides an overview of the Gouty Arthritis (Musculoskeletal Disorders) pipeline landscape. Gout is a type of arthritis where...

  • Musculoskeletal Disorder
  • Arthritis
  • World
  • China
  • Drug Approval
  • Cause-Specific Mortality Rate

Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...

  • Arthritis
  • World

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC. and Mylan N.V. The global arthritis monoclonal antibodies market is expected to grow from $44.14 billion in 2021 to $49.44 billion in 2022 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Canine Arthritis market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Canine Arthritis Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Canine Arthritis types, applications. Further, Canine Arthritis market...

  • Arthritis
  • World

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Healthcare
  • Arthritis
  • Autoimmune Disease
  • World
  • United States
  • Auto-Immune Diseases Prevalence
  • Health Expenditure

Rheumatoid Arthritis Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Rheumatoid Arthritis Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Rheumatoid Arthritis Drugs types, applications....

  • Arthritis
  • World

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc, AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, and Mylan N.V. The global arthritis monoclonal antibodies market is expected to grow from $44.82 billion in 2020 to $48.08 billion in 2021 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Drugs in Development, 2021, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis...

  • Arthritis
  • World

Gouty Arthritis (Gout) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis – Pipeline Review, H1 2020, provides an overview of the Gouty Arthritis (Musculoskeletal Disorders) pipeline landscape. Gout is a type of arthritis...

  • Musculoskeletal Disorder
  • Arthritis
  • World
  • China
  • Sweden
  • Cause-Specific Mortality Rate
  • Drug Approval

Canine Arthritis Market Report Overview Canine Arthritis market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Canine Arthritis market types and applications. It is a focused study on Canine Arthritis market space including global and regional...

  • Arthritis
  • World
  • APAC
  • Health Provider Density

Rheumatoid Arthritis Drugs Market Report Overview Rheumatoid Arthritis Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Rheumatoid Arthritis Drugs market types and applications. It is a focused study on Rheumatoid Arthritis Drugs...

  • Arthritis
  • World
  • APAC
  • Health Provider Density

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target constitutes close to 53 molecules....

  • Arthritis
  • Pharmaceutical
  • World
  • China
  • Stem Cell Transplantation
  • Prescription Drug Sales

Abstract: - Global Autoinjectors Market to Reach $118.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Autoinjectors estimated at US$35.1 Billion in the year 2020, is projected to reach a revised size of US$118.6 Billion by 2027, growing at a CAGR of 19% over the analysis period 2020-2027. Rheumatoid...

  • Arthritis
  • Neurological Disorder
  • World
  • China
  • United States

Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inflammatory Disease Marker Tests pipeline products...

  • Arthritis
  • Clinical Trial
  • World
  • United Kingdom
  • France
  • Medical Technology Density
  • Direct Sales

Rheumatoid Arthritis - Epidemiology Forecast to 2029 Summary Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity.The condition manifests itself in multiple joints in the body (Mayo Clinic, 2019;...

  • Arthritis
  • World
  • Auto-Immune Diseases Prevalence
  • Smoking Prevalence

Global Rheumatoid Arthritis Drugs Market 2022-2026 The analyst has been monitoring the rheumatoid arthritis drugs market and it is poised to grow by $ 14.90 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the rheumatoid arthritis drugs market provides a holistic analysis, market...

  • Arthritis
  • World
  • Biologics Penetration Rate

Osteonecrosis - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Pipeline Review, H2 2020, provides an overview of the Osteonecrosis (Musculoskeletal Disorders) pipeline landscape. Osteonecrosis is bone death caused by poor blood...

  • Cell Therapy
  • Therapy
  • Arthritis
  • World
  • Cause-Specific Mortality Rate
  • Business Birth

Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc, AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, and Mylan N.V. The global arthritis monoclonal antibodies market is expected to decline from $46.48 billion in 2019 to $45.18 billion in 2020 at a compound annual growth...

  • Monoclonal Antibody
  • Arthritis
  • World
  • Biologics Sales

Rheumatoid Arthritis Drugs Market by Drug Class (Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, and Others), Route of Administration (Oral and Parenteral), and Sales Channel (Prescription-based Drugs, and Over-the-counter Drugs): Global Opportunity Analysis and Industry...

  • Arthritis
  • Anti Rheumatic
  • World

Abstract: - Global C-reactive Protein Testing Market to Reach $1.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for C-reactive Protein Testing estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 1.4% over the analysis period...

  • Clinical Chemistry
  • Arthritis
  • World
  • China
  • United States

“Etanercept– Biosimilar 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Etanercept Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of...

  • Monoclonal Antibody
  • Autoimmune Disease
  • Arthritis
  • Dermatological Condition
  • United States
  • World
  • Taiwan
  • China

Arthritis (Musculoskeletal) - Drugs in Development, 2021 Summary Arthritis (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arthritis, complete with...

  • Arthritis
  • Therapy
  • Research And Development
  • Drug Development
  • World

Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 Summary Juvenile Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 provides an overview of the Juvenile Rheumatoid Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Arthritis
  • World

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Tyrosine Protein Kinase JAK3 - Drugs In...

  • Autoimmune Disease
  • Arthritis
  • Pharmaceutical
  • World
  • Japan
  • Cause-Specific Mortality Rate
  • Prescription Drug Sales

The Global Autoinjectors Market size is expected to reach $5.3 billion by 2026, rising at a market growth of 17.6% CAGR during the forecast period. An autoinjector is a medical device consist of a syringe having a spring-charged needle containing a pre-charged dosage of drugs and is designed to administer a dose of a specific drug. These injectors...

  • Neurological Disorder
  • Arthritis
  • Home Healthcare
  • World
  • APAC
  • North America
  • Europe
  • Health Expenditure
  • Pharmaceutical Production

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Tyrosine-protein kinase JAK3 is an enzyme encoded by the JAK3 gene....

  • Pharmaceutical
  • Autoimmune Disease
  • Arthritis
  • World
  • Japan
  • Drug Approval
  • Medical Technology Density

Rheumatoid Arthritis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H2 2020, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis (RA) is an autoimmune...

  • Arthritis
  • World